Survey reveals ‘key barriers’ limiting PCSK9is prescribing
Just 6% of cardiologists are currently prescribing PCSK9is, despite 97% believing in their abilities.
Read More
Tag: cardiologist
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
